DUKE UNIVERSITY
SCHOOL OF MEDICINE
DUKEHEALTH.ORG
| Clinical Trials |
| Clinical Trials | Previous Clinical Trials |
Clinical trials are an important part of ongoing research at Duke. Click each link listed below to read an overview of the trial and registries that are open for enrollment. New trials become available frequently.
Open trials currently recruiting participants
- The Genetics of Antiphospholipid Antibody Syndrome
- Antiphospholipid Syndrome in Pregnancy
- Genomics of Thrombosis Risk
- STAR Trial
- SOX Study
- Save Onco / Icon VTE
- Daltecan Trial
- The BRIDGE Study
- Discharge Alert: A Quality Improvement Initiative
- Apixaban 056 Trial: Treatment of Deep Vein Thrombosis and Pulmonary Embolism
- Apixaban 057: Evaluating the Use of Apixaban for Recurrent VTE
Open trials currently active, but participant recruitment is closed:
Duke University is proud to head the Rare Thrombotic Disease Consortium, leading these research studies at Duke University Medical Center and other participating sites:
Open trials currently active and recruiting participants:
Take Action! Join the The RTDC Patient Contact Registy
Questions about these studies, or to inquire as to participation with one of the studies, please contact the Hematology and Thrombosis Center team at htcteam@duke.edu.
Please review the below links to view information regarding clinical trials and registries available to certain patient populations through specific clinical programs within the Hemostasis & Thrombosis Center.
DHTS STRATEGIC WEB SERVICES